Showing results (181-190 of 337) with videos related to

Sort By:
Pageof 34
Current Gene Therapy|June 8, 2004
Therapeutic angiogenesis using hepatocyte growth factor (HGF)Ryuichi Morishita, Motokuni Aoki, Naotaka Hashiya, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|April 10, 2004
Efficacy and safety of the selective aldosterone blocker eplerenone in Japanese patients with hypertension: a randomized, double-blind, placebo-controlled, dose-ranging studyTakao Saruta, Shigeru Kageyama, Toshio Ogihara, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|March 13, 2010
Variation in OSBPL10 is associated with dyslipidemiaHiroshi Koriyama, Hironori Nakagami, Tomohiro Katsuya, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|November 27, 2007
Renal-protective effect of T-and L-type calcium channel blockers in hypertensive patients: an Amlodipine-to-Benidipine Changeover (ABC) studyMitsuru Ohishi, Takashi Takagi, Norihisa Ito, et al.
Hypertension (Dallas, Tex. : 1979)|September 7, 2002
Mitogenic activity of oxidized lipoprotein (a) on human vascular smooth muscle cellsNorio Komai, Ryuichi Morishita, Shingo Yamada, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|March 18, 2008
Gene polymorphism of myospryn (cardiomyopathy-associated 5) is associated with left ventricular wall thickness in patients with hypertensionHironori Nakagami, Yasushi Kikuchi, Tomohiro Katsuya, et al.
Diabetes Research and Clinical Practice|May 1, 2007
Present state of diabetes management in the elderly, JapanTomomi Fujisawa, Hiroshi Ikegami, Koji Nojima, et al.
Hypertension (Dallas, Tex. : 1979)|July 10, 2002
Angiogenesis and antifibrotic action by hepatocyte growth factor in cardiomyopathyYoshiaki Taniyama, Ryuichi Morishita, Motokuni Aoki, et al.
Pageof 34